MDT 68.74 Medtronic Inc $MDT Hit a 52 week high of
Post# of 99
Posted On: 11/06/2014 11:44:41 PM
MDT 68.74 Medtronic Inc $MDT Hit a 52 week high of 69.10 Closing the day 11/06/14 at 68.74 +0.04 +0.06% With a day low of 68.48 and a total volume of 7,329,513.
MDT Recent Posts: http://investorshangout.com/Medtronic-Inc-MDT-51763/
MDT Medtronic Inc Recent Headline News
Final Glance: Medical Devices companies
AP - Thu Nov 06, 6:13PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.19 (-0.80), JNJ: 109.01 (+0.19), MDT: 68.74 (+0.04), BAX: 71.60 (+0.70)
Midday Glance: Medical Devices companies
AP - Thu Nov 06, 12:17PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.19 (-0.80), JNJ: 109.01 (+0.19), MDT: 68.74 (+0.04), BAX: 71.60 (+0.70)
Early Glance: Medical Devices companies
AP - Thu Nov 06, 9:51AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.19 (-0.80), JNJ: 109.01 (+0.19), MDT: 68.74 (+0.04), BAX: 71.60 (+0.70)
Top 2 MedTech Stocks, Poised to Gain on Earnings this Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:36AM CST
Medical device is one of such sectors which are projected to be highly affected by the midterm election results.
DSCI: 9.00 (+0.05), MDT: 68.74 (+0.04), UNIS: 3.49 (-0.05), COV: 92.60 (-0.72), SHPG: 199.95 (+1.34), ABBV: 62.71 (+0.17), WAG: 66.65 (+0.99)
'Fast Money' Recap: Tesla's a Buy Despite the 4Q Guidance
at The Street - Thu Nov 06, 4:00AM CST
The trading panel discussed earnings reports from Tesla, Whole Foods Market and Qualcomm.
WFM: 44.85 (+4.86), TSLA: 241.22 (+10.25), FEYE: 30.04 (+0.92), MDT: 68.74 (+0.04), OIH: 44.28 (+0.54), QCOM: 70.58 (-6.62), SO: 47.01 (-0.95), PANW: 106.11 (+3.59)
After Yesterday's Rally of 1.13% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Nov 05, 3:45PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $68.28 to a high of $69.01. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $68.41 on volume of 11.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 68.74 (+0.04)
SmarTrend Watching for Potential Pullback in Shares of Medtronic After 1.13% Gain
Comtex SmarTrend(R) - Wed Nov 05, 3:44PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $68.28 to a high of $69.01. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $68.41 on volume of 11.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 68.74 (+0.04)
Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 68.74 (+0.04), GWPH: 74.38 (+3.04), ABAX: 53.84 (-0.61), COV: 92.60 (-0.72)
GOP Win Lifts TransCanada, Medical Device, Coal Stocks
at Investor's Business Daily - Wed Nov 05, 1:35PM CST
Prospects for approval of the Keystone XL pipeline, and for Calgary-based pipeline operator TransCanada (TRP), brightened after the GOP gained control of the Senate Tuesday. The power shift in Washington is also expected to benefit medical device...
BSX: 13.36 (+0.03), BTU: 10.84 (+0.06), MDT: 68.74 (+0.04), TRP: 49.22 (-0.72), STJ: 66.04 (+0.82), ANR: 2.52 (+0.09)
Medtronic (MDT) Breaks Through Resistance at $68.35
Comtex SmarTrend(R) - Wed Nov 05, 8:57AM CST
Shares of Medtronic (NYSE:MDT) have bullishly opened above the pivot of $67.87 today and have reached the first resistance level of $68.35. Analysts will be watching for a cross of the next upside pivot targets of $68.77 and $69.67.
MDT: 68.74 (+0.04)
Republicans Grab Senate: Which Stocks Will Fare Well? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:19AM CST
The Republican win will certainly bolster stocks and give investors more chances to earn.
GD: 141.56 (-0.39), LMT: 189.88 (+0.15), MDT: 68.74 (+0.04), QDEL: 28.67 (+0.38), XOM: 96.26 (+1.19), CLF: 10.54 (-0.61), BA: 124.58 (+0.36), NUVA: 41.93 (+0.18), ANR: 2.52 (+0.09), BSX: 13.36 (+0.03), VLO: 50.24 (+0.60), BTU: 10.84 (+0.06), ABAX: 53.84 (-0.61), IMO: 46.89 (+0.34), ACI: 2.42 (+0.07)
New Harvard Business Review Insight Center, Sponsored by Medtronic, Features Online Forum Focused on Innovating for Value in Healthcare
Thomson Reuters ONE - Wed Nov 05, 8:01AM CST
MINNEAPOLIS, Nov. 5, 2014 - Today marks the launch of a new Harvard Business Review (HBR) Insight Center, exclusively sponsored by Medtronic, which provides a forum for thought-leading commentary, editorial content and dialogue focused on innovating for value in healthcare. The Insight Center is a collaboration between HBR and the New England Journal of Medicine (NEJM) and provides an online forum for leaders, managers and others in healthcare.
MDT: 68.74 (+0.04)
Covidien to Sell Stellarex DCB to Spectranetics for $30M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 5:07PM CST
Divesture of Covidien plc's (COV) Stellarex DCB is subject to the approval of the Federal Trade Commission and other regulatory agencies, as well as closure of the Medtronic-Covidien merger, which is slated to complete by early 2015.
BCR: 164.97 (+0.39), MDT: 68.74 (+0.04), GWPH: 74.38 (+3.04), COV: 92.60 (-0.72)
Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study
Thomson Reuters ONE - Tue Nov 04, 11:00AM CST
Consistent Outcomes Despite Common and Challenging Comorbidity
MDT: 68.74 (+0.04)
Medtronic of Canada Recognized as One of Canada's Top 100 Employers for 2015 -- for the Fifth Year Running
Marketwire Canada - Tue Nov 04, 5:00AM CST
Medtronic of Canada Ltd., a trusted Canadian leader in innovative medical technologies and health system solutions, is pleased to have been recognized as one of Canada's Top 100 Employers for 2015, for the fifth year in a row. Medtronic's employee engagement initiatives, philanthropic activities, and a top tier benefits package are among some of the many reasons Medtronic is considered a top employer.
MDT: 68.74 (+0.04)
Will Covidien (COV) Disappoint Earnings Estimates in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 2:00PM CST
Covidien plc (COV) is set to report fourth-quarter fiscal 2014 results on Nov 5.
ACT: 250.38 (+2.47), MDT: 68.74 (+0.04), COV: 92.60 (-0.72), HSIC: 130.31 (+8.10)
MDT Recent Posts: http://investorshangout.com/Medtronic-Inc-MDT-51763/
MDT Medtronic Inc Recent Headline News
Final Glance: Medical Devices companies
AP - Thu Nov 06, 6:13PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.19 (-0.80), JNJ: 109.01 (+0.19), MDT: 68.74 (+0.04), BAX: 71.60 (+0.70)
Midday Glance: Medical Devices companies
AP - Thu Nov 06, 12:17PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.19 (-0.80), JNJ: 109.01 (+0.19), MDT: 68.74 (+0.04), BAX: 71.60 (+0.70)
Early Glance: Medical Devices companies
AP - Thu Nov 06, 9:51AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.19 (-0.80), JNJ: 109.01 (+0.19), MDT: 68.74 (+0.04), BAX: 71.60 (+0.70)
Top 2 MedTech Stocks, Poised to Gain on Earnings this Season - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:36AM CST
Medical device is one of such sectors which are projected to be highly affected by the midterm election results.
DSCI: 9.00 (+0.05), MDT: 68.74 (+0.04), UNIS: 3.49 (-0.05), COV: 92.60 (-0.72), SHPG: 199.95 (+1.34), ABBV: 62.71 (+0.17), WAG: 66.65 (+0.99)
'Fast Money' Recap: Tesla's a Buy Despite the 4Q Guidance
at The Street - Thu Nov 06, 4:00AM CST
The trading panel discussed earnings reports from Tesla, Whole Foods Market and Qualcomm.
WFM: 44.85 (+4.86), TSLA: 241.22 (+10.25), FEYE: 30.04 (+0.92), MDT: 68.74 (+0.04), OIH: 44.28 (+0.54), QCOM: 70.58 (-6.62), SO: 47.01 (-0.95), PANW: 106.11 (+3.59)
After Yesterday's Rally of 1.13% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Wed Nov 05, 3:45PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $68.28 to a high of $69.01. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $68.41 on volume of 11.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 68.74 (+0.04)
SmarTrend Watching for Potential Pullback in Shares of Medtronic After 1.13% Gain
Comtex SmarTrend(R) - Wed Nov 05, 3:44PM CST
Medtronic (NYSE:MDT) traded in a range yesterday that spanned from a low of $68.28 to a high of $69.01. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $68.41 on volume of 11.6 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MDT: 68.74 (+0.04)
Covidien (COV) Beats on Q4 Earnings, Sales; Both Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 1:50PM CST
Covidien plc (COV) reported fourth-quarter fiscal 2014 earnings of $1.15 per share, which beat the Zacks Consensus Estimate by 14 cents.
MDT: 68.74 (+0.04), GWPH: 74.38 (+3.04), ABAX: 53.84 (-0.61), COV: 92.60 (-0.72)
GOP Win Lifts TransCanada, Medical Device, Coal Stocks
at Investor's Business Daily - Wed Nov 05, 1:35PM CST
Prospects for approval of the Keystone XL pipeline, and for Calgary-based pipeline operator TransCanada (TRP), brightened after the GOP gained control of the Senate Tuesday. The power shift in Washington is also expected to benefit medical device...
BSX: 13.36 (+0.03), BTU: 10.84 (+0.06), MDT: 68.74 (+0.04), TRP: 49.22 (-0.72), STJ: 66.04 (+0.82), ANR: 2.52 (+0.09)
Medtronic (MDT) Breaks Through Resistance at $68.35
Comtex SmarTrend(R) - Wed Nov 05, 8:57AM CST
Shares of Medtronic (NYSE:MDT) have bullishly opened above the pivot of $67.87 today and have reached the first resistance level of $68.35. Analysts will be watching for a cross of the next upside pivot targets of $68.77 and $69.67.
MDT: 68.74 (+0.04)
Republicans Grab Senate: Which Stocks Will Fare Well? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 8:19AM CST
The Republican win will certainly bolster stocks and give investors more chances to earn.
GD: 141.56 (-0.39), LMT: 189.88 (+0.15), MDT: 68.74 (+0.04), QDEL: 28.67 (+0.38), XOM: 96.26 (+1.19), CLF: 10.54 (-0.61), BA: 124.58 (+0.36), NUVA: 41.93 (+0.18), ANR: 2.52 (+0.09), BSX: 13.36 (+0.03), VLO: 50.24 (+0.60), BTU: 10.84 (+0.06), ABAX: 53.84 (-0.61), IMO: 46.89 (+0.34), ACI: 2.42 (+0.07)
New Harvard Business Review Insight Center, Sponsored by Medtronic, Features Online Forum Focused on Innovating for Value in Healthcare
Thomson Reuters ONE - Wed Nov 05, 8:01AM CST
MINNEAPOLIS, Nov. 5, 2014 - Today marks the launch of a new Harvard Business Review (HBR) Insight Center, exclusively sponsored by Medtronic, which provides a forum for thought-leading commentary, editorial content and dialogue focused on innovating for value in healthcare. The Insight Center is a collaboration between HBR and the New England Journal of Medicine (NEJM) and provides an online forum for leaders, managers and others in healthcare.
MDT: 68.74 (+0.04)
Covidien to Sell Stellarex DCB to Spectranetics for $30M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 5:07PM CST
Divesture of Covidien plc's (COV) Stellarex DCB is subject to the approval of the Federal Trade Commission and other regulatory agencies, as well as closure of the Medtronic-Covidien merger, which is slated to complete by early 2015.
BCR: 164.97 (+0.39), MDT: 68.74 (+0.04), GWPH: 74.38 (+3.04), COV: 92.60 (-0.72)
Medtronic Drug-Coated Balloon for Peripheral Artery Disease Also Benefits Patients with Diabetes in Landmark Study
Thomson Reuters ONE - Tue Nov 04, 11:00AM CST
Consistent Outcomes Despite Common and Challenging Comorbidity
MDT: 68.74 (+0.04)
Medtronic of Canada Recognized as One of Canada's Top 100 Employers for 2015 -- for the Fifth Year Running
Marketwire Canada - Tue Nov 04, 5:00AM CST
Medtronic of Canada Ltd., a trusted Canadian leader in innovative medical technologies and health system solutions, is pleased to have been recognized as one of Canada's Top 100 Employers for 2015, for the fifth year in a row. Medtronic's employee engagement initiatives, philanthropic activities, and a top tier benefits package are among some of the many reasons Medtronic is considered a top employer.
MDT: 68.74 (+0.04)
Will Covidien (COV) Disappoint Earnings Estimates in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 2:00PM CST
Covidien plc (COV) is set to report fourth-quarter fiscal 2014 results on Nov 5.
ACT: 250.38 (+2.47), MDT: 68.74 (+0.04), COV: 92.60 (-0.72), HSIC: 130.31 (+8.10)
(0)
(0)